檢索結果 - Akira Mima

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Incretin-Based Therapy for Prevention of Diabetic Vascular Complications 由 Akira Mima

    發表在 Journal of Diabetes Research (2016-01-01)
    獲取全文
    Article


  2. 2

    Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic Targets 由 Akira Mima

    發表在 Journal of Diabetes Research (2013-01-01)
    獲取全文
    Article


  3. 3

    Mitochondria-targeted drugs for diabetic kidney disease 由 Akira Mima

    發表在 Heliyon (2022-02-01)
    獲取全文
    Article


  4. 4

    Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study 由 Akira Mima

    發表在 Scientific Reports (2022-10-01)
    獲取全文
    Article


  5. 5

    IgA nephropathy after COVID-19 vaccination and analysis of reported cases 由 Akira Mima, Shinji Lee

    發表在 Heliyon (2023-06-01)
    獲取全文
    Article


  6. 6

    Tirzepatide Reduces Fat Mass and Provides Good Glycaemic Control in Type 2 Diabetes Patients Undergoing Haemodialysis: A Single‐Centre Retrospective Study 由 Akira Mima, Yasuhiro Horii

    發表在 Endocrinology, Diabetes & Metabolism (2024-05-01)
    獲取全文
    Article


  7. 7

    Inflammatory Regulation in Diabetes and Metabolic Dysfunction 由 Jixin Zhong, Quan Gong, Akira Mima

    發表在 Journal of Diabetes Research (2017-01-01)
    獲取全文
    Article


  8. 8

    Incidence of acute kidney disease after receiving hematopoietic stem cell transplantation: a single-center retrospective study 由 Akira Mima, Kousuke Tansho, Dai Nagahara, Kazuo Tsubaki

    發表在 PeerJ (2019-02-01)
    獲取全文
    Article


  9. 9

    Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes 由 Toshinori Yasuzawa, Tomomi Nakamura, Shigeru Ueshima, Akira Mima

    發表在 Journal of Diabetes Research (2021-01-01)
    獲取全文
    Article


  10. 10

    Predictive significance of glomerular insulin receptor substrate-1 in patients with diabetic kidney disease 由 Akira Mima, Ami Murakami, Rina Lee, Shinji Lee

    發表在 Metabolism Open (2023-06-01)
    獲取全文
    Article


  11. 11

    Combat Diabetic Nephropathy: From Pathogenesis to Treatment 由 Tomohito Gohda, Akira Mima, Ju-Young Moon, Keizo Kanasaki

    發表在 Journal of Diabetes Research (2014-01-01)
    獲取全文
    Article


  12. 12

    Effect of finerenone on nephrotic syndrome in patients with diabetic kidney disease 由 Akira Mima, Yuta Saito, Keishi Matsumoto, Takahiro Nakamoto, Shinji Lee

    發表在 Metabolism Open (2024-06-01)
    獲取全文
    Article


  13. 13

    Case Report: IgG4-related kidney disease complicated by interstitial pneumonia [version 1; peer review: 1 approved, 2 approved with reservations] 由 Akira Mima, Shinji Lee, Hidemasa Gotoda, Ryosuke Akai, Rina Lee, Ami Murakami

    發表在 F1000Research (2023-08-01)
    獲取全文
    Article


  14. 14

    Effect of dapagliflozin on eGFR slope in IgA nephropathy based on renal pathological assessment using image analysis software 由 Akira Mima, Takahiro Nakamoto, Keishi Matsumoto, Yuta Saito, Takaaki Morikawa, Shinji Lee

    發表在 Metabolism Open (2025-12-01)
    獲取全文
    Article


  15. 15

    Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: A systemic review and meta-analysis 由 Akira Mima, Hidemasa Gotoda, Rina Lee, Ami Murakami, Ryosuke Akai, Shinji Lee

    發表在 Metabolism Open (2023-03-01)
    獲取全文
    Article


  16. 16

    Case Report: IgG4-related kidney disease complicated by interstitial pneumonia [version 2; peer review: 1 approved, 2 approved with reservations] 由 Akira Mima, Shinji Lee, Hidemasa Gotoda, Ryosuke Akai, Rina Lee, Ami Murakami

    發表在 F1000Research (2023-09-01)
    獲取全文
    Article


  17. 17

    Effect of finerenone on diabetic kidney disease outcomes with estimated glomerular filtration rate below 25 mL/min/1.73 m2 由 Akira Mima, Rina Lee, Ami Murakami, Hidemasa Gotoda, Ryosuke Akai, Sayumi Kidooka, Takahiro Nakamoto, Suguru Kido, Shinji Lee

    發表在 Metabolism Open (2023-09-01)
    獲取全文
    Article


  18. 18

    Protein inhibitor of activated STAT, PIASy regulates α-smooth muscle actin expression by interacting with E12 in mesangial cells. 由 Kazuo Torikoshi, Hideharu Abe, Takeshi Matsubara, Takahiro Hirano, Takayuki Ohshima, Taichi Murakami, Makoto Araki, Akira Mima, Noriyuki Iehara, Atsushi Fukatsu, Toru Kita, Hidenori Arai, Toshio Doi

    發表在 PLoS ONE (2012-01-01)
    獲取全文
    Article


  19. 19

    Porphyromonas gingivalis-derived lipopolysaccharide promotes mesangial cell fibrosis via transforming growth factor-beta1/Smad signaling pathway in high glucose 由 Eri Sakaniwa, Risako Mikami, Koji Mizutani, Akira Mima, Daisuke Kido, Hiromi Kominato, Natsumi Saito, Masahiro Hakariya, Shu Takemura, Keita Nakagawa, Mari Sugimoto, Ayu Sugiyama, Takanori Iwata

    發表在 Journal of Dental Sciences (2025-04-01)
    獲取全文
    Article


檢索工具: